FDA Actions to Remove Unapproved Drugs from the Market by Drug

Ascorbic acid injection

Cocaine hydrochloride solution products

Dehydrated Alcohol

Isometheptene-containing drugs

Isoxsuprine

Local anesthetics

Meperidine hydrochloride and promethazine hydrochloride drugs

Nonsteroidal anti-inflammatory drugs (NSAIDs)

Otic drugs

Federal Register notice: Unapproved and misbranded otic prescription drug products; Enforcement action dates (July 2, 2015)

Tetracaine ophthalmic solution

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

FDA Actions to Remove Unapproved Drugs from the Market by Drug

Distribution channels: Healthcare & Pharmaceuticals Industry

EIN Presswire's priority is author transparency. We do our best to weed out false and misleading content. The content above is the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.